5
4.2.8 7-methoxy-3-methylisochroman-4-one (2h) Colorless oil;
1H NMR (300 MHz, CDCl3) δ: 7.93 (d, J = 8.6 Hz, 1H), 6.83 (dd,
J = 8.6 Hz, 2.4 Hz, 1H), 6.58 (d, J = 2.4 Hz, 1H), 4.81 (s, 1H),
4.24 (q, J = 6.6 Hz, 1H), 3.81 (s, 3H), 1.45 (d, J = 6.6 Hz, 3H);
13C NMR (75 MHz, CDCl3) δ: 194.74, 163.92, 144.48, 129.22,
122.72, 114.05, 108.32, 78.26, 66.91, 55.50, 15.73; MS-ESI:
(ESI, pos.ion) m/z: 193.1 [M+H]+; HRMS (ESI) calculated for
C12H15O4 [M+H]+ 193.0865, found 193.0845.
DMF (20 ml) was added with stirring, and to the stirred
ACCEPTED MANUSCRIPT
solution 2-bromo-N-methoxy-N-methyl propanamide (7.5 mmol)
was added. The mixture was cooled with ice-water bath and
sodium hydride (15 mmol) was added with stirring. Cooling bath
was removed and the mixture was stirred at rt for further 30 min.
The reaction mixture was quenched with water (20 mL),
extracted with ethyl acetate (3 ⅹ 20 mL), and the combined
organic layers were washed with brine, dried with Na2SO4 and
evaporated. The residue was separated with column
chromatography to afford 9 in 95% yield. Colorless oil; 1H NMR
(300 MHz, CDCl3): δ 7.45-7.24 (m, 11H), 6.83 (d, J = 8.8 Hz,
1H), 5.06 (s, 2H), 5.04 (s, 2H), 4.85 (d, J = 10.2 Hz, 1H), 4.57 (d,
J = 10.2 Hz, 1H),4.39 (q, J = 6.6 Hz, 1H), 3.52 (s, 3H), 3.11 (s,
3H), 1.45 (d, J = 6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ
151.54, 148.75, 137.32, 136.43, 131.77, 128.86, 128.65, 128.36,
128.22, 128.11, 127.60, 116.97, 115.37, 76.13, 71.84, 70.99,
65.55, 61.13, 32.24, 18.03; MS-ESI: (ESI, pos.ion) m/z: 514.1
[M+H]+; HRMS (ESI) calcd for C26H29BrNO5 [M+H]+ 514.1224,
found 514.1212.
4.2.9
7-(dimethylamino)-3-methylisochroman-4-one
(2i)
Yellow solid; 1H NMR (300 MHz, CDCl3) δ: 7.89 (d, J = 8.8 Hz,
1H), 6.61 (dd, J = 8.9 Hz, 2.5 Hz, 1H), 6.26 (d, J = 2.4 Hz, 1H),
4.81 (s, 2H), 4.19 (q, J = 6.6 Hz, 1H ), 3.04 (s, 3H), 1.48 (d, J =
6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ: 194.40, 153.67,
144.02, 128.87, 117.86, 110.94, 104.73, 78.25, 67.31, 40.05,
16.04; MS-ESI: (ESI, pos.ion) m/z: 205.8 [M+H]+; HRMS (ESI)
calculated for C12H15NO2Na [M+Na]+ 228.1000, found 228.0986.
4.2.10 7-fluoro-3-methylisochroman-4-one (2j) Yellow solid;
1H NMR (300 MHz, CDCl3) δ: 8.08 (dd, J = 8.6 Hz, 2.4 Hz, 1H),
7.08 (td, J = 8.6 Hz, 2.4 Hz, 1H), 6.89 (dd, J = 8.6 Hz, 2.4 Hz,
1H), 4.91 (s, 2H), 4.25 (q, J = 6.6 Hz, 1H), 1.52 (d, J = 6.6 Hz,
3H); 13C NMR (75 MHz, CDCl3) δ: 194.40, 167.48, 164.08,
145.11, 144.99, 130.08, 129.95, 125.94, 115.49, 115.19, 111.22,
110.92, 78.33, 66.61, 66.59, 15.58; MS-ESI: (ESI, pos.ion) m/z:
181.1 [M+H]+; HRMS (ESI) calculated for C10H10FO2 [M+H]+
181.0665, found 181.0655.
4.3.2 7,8-bis(benzyloxy)-3-methylisochroman-4-one (10) To a
solution of precursor 9 (1 mmol) in dry THF (10 mL), t-BuLi
(2.2 mmol) was added at -78 oC, and after 1 min, the reaction was
quenched by the addition of sat. NH4Cl (10 mL). Ethyl acetate
(15 mL) was added, the organic layer was separated, and the
aqueous phase was extracted with ethyl acetate (3ⅹ15 mL). The
combined organic extracts were dried (Na2SO4) and concentrated
in vacuo. Flash column chromatography afforded 10 in 93%
4.2.11 7-chloro-3-methylisochroman-4-one (2k) White solid;
1H NMR (300 MHz, CDCl3) δ: 7.96 (d, J = 8.4 Hz, 1H), 7.36 (dd,
J = 8.4 Hz, 1.8 Hz, 1H), 7.20 (s, 1H), 4.89 (s, 2H), 4.24 (q, J =
6.6 Hz, 1H), 1.51 (d, J = 6.6 Hz, 3 H); 13C NMR (75 MHz,
CDCl3) δ: 194.86, 143.57, 140.22, 128.51, 128.25, 127.70,
124.45, 78.47, 66.48, 15.64; MS-ESI: (ESI, pos.ion) m/z: 197.0
[M+H]+; HRMS (ESI) calculated for C10H10ClO2 [M+H]+
197.0369, found 197.0356.
1
yield. White solid; H NMR (300 MHz, CDCl3): δ 7.81 (d, J =
8.7 Hz, 1H), 7.47-7.32 (m, 10H), 7.03 (d, J = 8.7 Hz, 1H), 5.23 (s,
2H), 5.09-4.98 (m, 3H), 4.54 (d, J = 15.9 Hz, 1H), 4.10 (q, J =
6.9 Hz, 1H), 1.45 (d, J = 6.9 Hz, 3H); 13C NMR (75 MHz,
CDCl3): δ 194.92, 155.98, 142.16, 137.00, 136.64, 135.94,
128.77, 128.59, 128.54, 128.40, 127.52, 124.04, 123.37, 112.61,
77.66, 74.88, 70.82, 63.09, 15.64; MS-ESI: (ESI, pos.ion) m/z:
397.1 [M+Na]+; HRMS (ESI) calcd for C24H22NaO4 [M+Na]+
397.1410, found 397.1415.
4.2.12 3-methyl-7-(trifluoromethyl)isochroman-4-one (2m)
1
White solid; H NMR (300 MHz, CDCl3) δ: 8.15 (d, J = 8.2 Hz,
4.3.3 (±)-7, 8-dihydroxy-3-methylisochroman-4-one [(±)-XJP]
To a solution of 7, 8-bis (benzyloxy)-3-methylisochroman-4-one
10 (0.26 mmol) in THF (5 mL) was added Pd-C (0.02 g, 10%)
and the mixture was stirred under H2 atmosphere for 4 h at room
temperature. Then the reaction solution was passed through a
short diatomite pad and washed with THF. The combined organic
phase was concentrated in vacuo, and the residue was purified by
a short silica gel column chromatography to give (±)-XJP in 70%
1H), 7.65 (dd, J = 8.2 Hz, 0.6 Hz, 1H), 7.49 (s, 1H), 4.98 (s, 2H),
4.29 (q, J = 6.6 Hz, 1H), 1.53 (d, J = 6.6 Hz, 3 H); 13C NMR (75
MHz, CDCl3) δ: 194.80, 142.57, 136.23, 131.71, 127.50, 124.55,
124.50, 121.70, 121.65, 78.57, 66.68, 15.54; MS-ESI: (ESI,
pos.ion) m/z: 231.1 [M+H]+; HRMS (ESI) calculated for
C11H10F3O2 [M+H]+ 231.0633, found 231.0629.
4.2.13 5,10-dimethoxy-3-methyl-1H-benzo[g]isochromen-4(3H)
-one (2n) Yellow solid; 1H NMR (300 MHz, CDCl3) δ: 8.36 (d, J
= 8.2 Hz, 1H), 8.03 (d, J = 8.2 Hz, 1H,), 7.66 (m, 2H), 5.31 (d, J
= 15.0 Hz, 1H), 4.80 (d, J = 15.0 Hz, 1H), 4.22 (q, J = 6.6 Hz,
1H), 4.01 (s, 3H), 3.87 (s, 3H), 1.55 (d, J = 6.6 Hz, 3H); 13C
NMR (75 MHz, CDCl3) δ:195.71, 155.70, 146.50, 131.57,
129.52, 129.18, 128.09, 126.72, 125.00, 121.98; MS-ESI: (ESI,
pos.ion) m/z: 272.9 [M+H]+; HRMS (ESI) calculated for
C16H16NaO4 [M+Na]+ 295.0941, found 295.0945.
1
yield. White solid; H-NMR (300 MHz, DMSO-d6): δ 10.47 (s,
1H), 8.96 (s, 1H), 7.32 (d, J = 8.4 Hz, 1H), 6.84 (d, J = 8.4 Hz,
1H), 4.92 (d, J = 15.6 Hz, 1H), 4.69 (d, J = 15.6 Hz, 1H), 4.21 (q,
J = 6.6 Hz, 1H), 1.31 (d, J = 6.6 Hz, 3H); 13C-NMR (75 MHz,
DMSO-d6): δ 194.45, 150.46, 139.43, 129.95, 121.31, 118.61,
114.26, 76.44, 62.27, 15.50. MS-ESI: (ESI, neg.ion) m/z: 193.0
[M-H]-; HRMS (ESI) calcd for C10H9O4 [M-H]- 193.0506, found
193.0501.
1
4.2.14 6,7-dimethoxyisochroman-4-one (2o) Yellow solid; H
Acknowledgments
NMR (300 MHz, CDCl3) δ: 7.41 (s, 1H), 6.57 (s, 1H), 4.76 (s,
2H), 4.24 (s, 2H), 3.88 (s, 3H), 3.86 (s, 3H); 13C NMR (75 MHz,
CDCl3) δ: 192.73, 154.23, 148.76, 136.78, 122.72 107.52,
106.06, 72.91, 67.54, 56.18, 56.05; MS-ESI: (ESI, pos.ion) m/z:
208.92 [M+H]+; HRMS (ESI) calculated for C11H12O4 [M+H]+
209.0736, found 209.0750.
This study was financially supported by a grant from
“National Natural Science Fund (No. 81302635), the Project
Program of State Key Laboratory of Natural Medicines, China
Pharmaceutical University (No. SKLNMZZCX201404) and the
Project for Research and Innovation of Graduates in Colleges and
Universities of Jiangsu Province (KYLX_0611).
4.3. Procedure for total synthesis of (±)-XJP
4.3.1 2-((2,3-bis(benzyloxy)-6-bromobenzyl)oxy)-N-methoxy-
N-methyl propanamide (9). A 50 ml round bottom flask was
charged with compound 8 (5 mmol) and argonated. Anhydride
Supplementary Material